USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/12767
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHariton, Ion
dc.date.accessioned2020-11-10T07:28:47Z
dc.date.available2020-11-10T07:28:47Z
dc.date.issued2020-10
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/12767
dc.identifier.urihttps://stiinta.usmf.md/ro/manifestari-stiintifice/zilele-universitatii
dc.descriptionDepartment of Pharmacologyand Clinical Pharmacy, SUMPh “Nicolae Testemitanu”, Chisinau, The Republic of Moldova, Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină și Farmacie „Nicolae Testemițanu” din Republica Moldova, Ziua internațională a științei pentru pace și dezvoltareen_US
dc.description.abstractIntroduction According to the World Health Organization, pharmacovigilance is the science that deals with the detection, evaluation and prevention of adverse drug reactions. Increased interest in adverse reaction research continues to be the topical issue of the studies for reducing their incidence. In order to prevent and reduce the risk of adverse drug reactions and to improve the public health system, mechanisms for monitoring and evaluating the safety of medicines in medical practice are vital. This implies the existence of a well-organized pharmacovigilance system, pharmacovigilance being the key element in the medical offices and in the public health program. Purpose. The evaluation of the collection, management and monitoring of adverse reactions in the pharmacovigilance activity. Material and methods. The communication sheets of the adverse reactions received by the Pharmacovigilance Departement within the Medicines and Medical Devices Agency during the period from 2018 to 2019 were researched and evaluated. All communication sheets (93 sheets) - were received, analyzed, recorded in the database of adverse drug reactions and other suspected pharmaceutical products. Results. During the period from 2018 to 2019, 93 sheets of communication of adverse reactions were analyzed, among which 12 cases of inefficiency of the drug preparation. According to the data obtained regarding the group of patients we had examined there is a predominance of women vs. men (55% and 60%), which corresponds to the data of the researched literature. The predominant age is suitable for work: 30-50 years, with a share of 46% specific for both groups studied. Based on the obtained data, we found that it was a higher incidence of oral drugs administration (62%) and the predominance of solid pharmaceutical forms (tablets-36%, capsules-8%, powder-3%). The most commonly reported adverse reactions were of the following groups of drugs: antituberculosis drugs–85%, antibiotics–48^, perfusion solutions–22%, nonsteroidal anti¬inflammatory drugs -18%, contrast agents– 15%, antiretrovirals– 11%. Conclusions. The importance of avoiding and detecting adverse reactions is a goal of the future, which requires everyone's contribution to solving it, through the receptivity of reports, the active encouragement of medical workers and patients.en_US
dc.language.isoenen_US
dc.publisherUniversitatea de Stat de Medicină şi Farmacie "Nicolae Testemiţanu"en_US
dc.subjectpharmacovigilanceen_US
dc.subjectadverse reactionsen_US
dc.subjectevaluationen_US
dc.subjectmonitoringen_US
dc.titleThe aspects of pharmacovigilance in the Republic of Moldovaen_US
dc.typeOtheren_US
Appears in Collections:Culegere de postere

Files in This Item:
File Description SizeFormat 
THE_ASPECTS_OF_PHARMACOVIGILANCE_IN_THE_REPUBLIC_OF_MOLDOVA.pdf492.26 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback